Oatmeal diet days may improve insulin resistance in patients with type 2 diabetes mellitus

Forschende Komplementarmedizin

Volumn 20, Issue 6, 2013, Pages 465-468

  Zerm, Roland ^a,b   Helbrecht, Bert ^b   Jecht, Michael ^a   Hein, Angelika ^a   Millet, Elke ^a   Girke, Matthias ^a,b   Kröz, Matthias ^a,b  

^a Department of Internal Medicine Diabetology   (Germany)

^b Research Institute Havelhöhe FIH Havelhöhe Hospital   (Germany)

Author keywords

Beta glucan; Butyrate; Diet; Insulin resistance; Metabolic syndrome; Microbiota; Oat; Oatmeal

Indexed keywords

GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INSULIN;

AGED; CEREAL; DIET THERAPY; FEASIBILITY STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OAT; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY;

AGED; AVENA SATIVA; BLOOD GLUCOSE; CEREALS; DIABETES MELLITUS, TYPE 2; FEASIBILITY STUDIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; RETROSPECTIVE STUDIES;

EID: 84893092026     PISSN: 16614119     EISSN: 16614127     Source Type: Journal    
DOI: 10.1159/000357485     Document Type: Article

References (22)

1. Heidemann C, Du Y, Scheidt-Nave C: Wie hoch ist die Zahl der Erwachsenen mit Diabetes in Deutschland www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/ Degs/degs-w1/Symposium/degs-diabetes. pdf-blob=publicationFile (accessed 21.11.2013).
2. Rathmann W, Haastert B, Icks A, et al.: High prevalence of undiagnosed diabetes mellitus in Southern Germany: Target populations for efficient screening. The KORA survey 2000. Diabetologia 2003;46:182- 189.
3. Lammert A, Kratzsch J, Selhorst J, et al.: Clinical benefit of a short term dietary oatmeal intervention in patients with type diabetes and severe insulin resistance: A pilot study. Exp Clin Endocrinol Diabetes 2008;116:132-134.
4. Jandeleit-Dahm KAM, Gray SP: Insulin and cardiovascular disease: Biomarker or association Diabetologia 2012;55:3145-3151.
5. Dankner R, Shanik MH, Keinan-Boker L, Cohen C, Chetrit A: Effect of elevated basal insulin on cancer incidence and mortality in cancer incident patients: The Israel GOH 29-year follow-up study. Diabetes Care 2012;35:1538-1543.
6. Pyorala M, Miettinen H, Laakso M, Pyorala K: Plasma insulin and all-cause, cardiovascular, and noncardiovascular mortality: The 22-year follow-up results of the Helsinki Policemen Study. Diabetes Care 2000;23:1097-1102.
7. Sheehan MT: Current therapeutic options in type diabetes mellitus: A practical approach. Clin Med Res 2003;1:189-200.
8. Weickert MO, Pfeiffer AFH: Metabolic effects of dietary fiber consumption and prevention of diabetes. J Nutr 2008;138:439-442.
9. Tapola N, Karvonen H, Niskanen L, Mikola M, Sarkkinen E: Glycemic responses of oat bran products in type diabetic patients. Nutr Metab Cardiovasc Dis 2005;15:255-261.
10. Maki KC, Shinnick F, Seeley MA, et al.: Food products containing free tall oil-based phytosterols and oat beta-glucan lower serum total and LDL cholesterol in hypercholesterolemic adults. J Nutr 2003; 133:808-813.
11. Kedia G, Vazquez JA, Charalampopoulos D, Pandiella SS: In vitro fermentation of oat bran obtained by debranning with a mixed culture of human fecal bacteria. Curr Microbiol 2009;58:338-342.
12. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI: An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006;444:1027-1031.
13. Backhed F, Manchester JK, Semenkovich CF, Gordon JI: Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 2007;104:979-984.
14. Graessler J, Qin Y, Zhong H, et al.: Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type diabetes: Correlation with inflammatory and metabolic parameters. Pharmacogenomics J 2013; 13:514-522.
15. Qin J, Li Y, Cai Z, et al.: A metagenome-wide association study of gut microbiota in type diabetes. Nature 2012;490:55-60.
16. Queenan KM, Stewart ML, Smith KN, Thomas W, Fulcher RG, Slavin JL: Concentrated oat betaglucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutr J 2007;6:6.
17. Bugaut M, Bentejac M: Biological effects of shortchain fatty acids in nonruminant mammals. Annu Rev Nutr 1993;13:217-241.
18. Avivi-Green C, Polak-Charcon S, Madar Z, Schwartz B: Different molecular events account for butyrate-induced apoptosis in two human colon cancer cell lines. J Nutr 2002;132:1812-1818.
19. Canani RB, Costanzo MD, Leone L, Pedata M, Meli R, Calignano A: Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol 2011;17:1519-1528.
20. Moschen AR, Wieser V, Tilg H: Dietary factors: Major regulators of the gut's microbiota. Gut Liver 2012;6:411-416.
21. Weickert MO, Roden M, Isken F, et al.: Effects of supplemented isoenergetic diets differing in cereal fiber and protein content on insulin sensitivity in overweight humans. Am J Clin Nutr 2011;94:459-471.
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.